ROBERT L MD ZERBE
CIK 1220363 · last filed 2026-05-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.54M
Companies
6
Total Filings
65
Lifetime Open-Market Net
-$1.89M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VCEL | Director | 32,995 | $46.62 | $1.54M | -$1.89M | 29 | 2026-05-01 |
| Vericel Corp (ASTM) Delisted | Director | — | — | — | $0 | 5 | 2013-05-03 |
| HERON THERAPEUTICS, INC. /DE/ (APPA) Delisted | Director | 10,104 | — | — | $0 | 4 | 2010-05-26 |
| Vericel Corp (ASTMD) Delisted | Director | — | — | — | $0 | 1 | 2010-03-15 |
| ANESIVA, INC. (ANSV) Delisted | Director | 0 | — | — | $0 | 2 | 2008-05-12 |
| HERON THERAPEUTICS, INC. /DE/ (APPAD) Delisted | Director | 52,558 | — | — | $0 | 1 | 2007-05-25 |
Recent Filings · Page 3 of 7
65 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-16 | VCEL | Sell (S) | −2,200 | -$83.8K | EDGAR |
| 2024-01-12 | VCEL | Notice (144) | −2,200 | -$83.8K | EDGAR |
| 2023-11-17 | VCEL | Sell (S) | −300 | -$11.4K | EDGAR |
| 2023-11-15 | VCEL | Notice (144) | −300 | -$11.4K | EDGAR |
| 2023-07-17 | VCEL | Sell (S) | −1,000 | -$38.8K | EDGAR |
| 2023-07-14 | VCEL | Notice (144) | −1,000 | -$38.8K | EDGAR |
| 2023-06-26 | VCEL | Sell (S) | −3,000 | -$108.0K | EDGAR |
| 2023-06-22 | VCEL | Notice (144) | −3,000 | -$108.0K | EDGAR |
| 2023-05-05 | VCEL | Grant (A) | — | $0 | EDGAR |
| 2023-04-28 | VCEL | Exer (M) | +2,600 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.